GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
2,984
Funds Holding Change
-12
Funds Holding Growth
-0.4%
Value
$511B
Holding in Top 10
457
Top 10 Change
+16
Top 10 Growth
+4%
Value Growth
-4%
New
120
Increased
1,282
Reduced
1,392
Closed
94
Capital Inflow
$15.6B
Capital Outflow
$22.9B
Net Capital Flow
-$7.35B
Capital Flow Change
-$13.6B
Calls
$4.27B
Puts
$5.83B
Net Calls
-$1.56B
Put/Call Ratio
1.37